Obstetrics & Gynecology Doctors in Bay City, MI Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Douglas Jay Saylor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3175 Professional Drive, Bay City, MI 48706 Phone: 989-667-3377    Fax: 989-667-9991

Dr. Sang H Oh, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 200 S Wenona St, Suite #291, Bay City, MI 48706 Phone: 989-892-5548    Fax: 989-892-0859

Dr. Mary A Durbin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 714 S Trumbull St, Bay City, MI 48708 Phone: 989-895-9500    Fax: 989-895-2520

William John Vandenbelt, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3175 W Professional Dr, Bay City, MI 48706 Phone: 989-667-3377    Fax: 989-667-9991

Bradley W Merrills, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3175 W Professional Drive, Bay City, MI 48706 Phone: 989-667-3777    Fax: 989-667-9991

News Archive

Girls who gain weight rapidly at childhood are more likely to be obese at age 24

Girls who gain weight more rapidly between the ages of 5 and 15 are more likely to be obese at age 24, according to researchers.

State highlights: N.Y. sues drugmaker over Alzheimer's drug switch; Ariz. Republican resigns over Medicaid remarks

New York State's attorney general filed an antitrust lawsuit on Monday seeking to stop a pharmaceutical company from forcing patients with Alzheimer's disease to switch to a new version of a widely used drug. The lawsuit contends that the switch is designed to blunt competition from low-priced generic versions of the medication (Pollack, 9/15).

Grant awarded to support six students in FNP program

The University of Miami School of Nursing and Health Studies is receiving a grant from the Dr. John T. Macdonald Foundation in the amount of $30,000 to support six students in its Family Nurse Practitioner Master of Science of Nursing program.

FDA Advisory Committee recommendation against flibanserin will not affect LibiGel program: BioSante

BioSante Pharmaceuticals, Inc. commented today that the recommendation on June 18, 2010 by the FDA Advisory Committee regarding the safety and efficacy of flibanserin (Boehringer-Ingelheim) will have no impact on its own ongoing development program or approval pathway for LibiGel (testosterone gel), for the treatment of hypoactive sexual desire disorder (HSDD).

Read more Medical News

› Verified 4 days ago